Introduction
As of November 1, Valisure, an independent research company, testing products or harmful components, identified an extraordinarily high amount of benzene in several dry shampoo hair products.
Benzene is a known carcinogen that has been widely mentioned over the last couple of years due to the recalls of products, such as aerosol sunscreen containing it. “High levels of benzene, a cancer-causing chemical, have been detected in more brands and batches of dry shampoo products, according to a new report from Valisure, an independent laboratory.
Aerosol Dry Shampoos
Some of these brands that contain benzene at high parts per million include Dove, Nexxus, Suave, TIGI, and TRESemmé.
Below is a list of the products that have been affected by the benzene:
Dove
Dove Dry Shampoo Volume and Fullness
Dove Dry Shampoo Fresh Coconut
Dove Dry Shampoo Fresh and Floral
Dove Dry Shampoo Ultra Clean
Dove Dry Shampoo Invisible
Dove Dry Shampoo Detox and Purify
Dove Dry Shampoo Clarifying Charcoal
Dove Dry Shampoo Go Active
Nexxus
Nexxus Dry Shampoo Refreshing Mist
Nexxus Inergy Foam Shampoo
Suave
Suave Dry Shampoo Hair Refresher
Suave Professionals Dry Shampoo Refresh and Revive
TRESemmé
TRESemmé Dry Shampoo Volumizing
TRESemmé Dry Shampoo Fresh and Clean
TRESemmé Pro Pure Dry Shampoo
Bed Head
Bed Head Oh Bee Hive Dry Shampoo
Bed Head Oh Bee Hive Volumizing Dry Shampoo
Bed Head Dirty Secret Dry Shampoo
Rockaholic
Bed Head Rockaholic Dirty Secret Dry Shampoo
The Michael Brady Lynch Firm
here at the Michael Brady, Lynch firm, we are currently taking on cases involving benzene in hair products, sunscreen, and any other harmful products that have been recalled from the market. If you or a loved, one has been injured, please give us a call at 888-585-5970.
Date: November 4, 2022
Author: Brandon Salter
Citations
https://www.valisure.com/valisure-newsroom/valisure-detects-benzene-in-dry-shampoo.
https://abc7news.com/amp/dry-shampoo-recall-benzene-cancer-valisure-report/12412752/.
https://abc7news.com/amp/dry-shampoo-recall-benzene-cancer-valisure-report/12412752/